The U.S. Special 301 Reports, 1989 to 2009

The USTR's Special 301 Report has been issued every year beginning in 1989. The Executive Summary of the 2009 report says:

The “Special 301” Report is an annual review of the global state of intellectual property rights (IPR) protection and enforcement, conducted by the Office of the United States Trade Representative (USTR) pursuant to Section 182 of the Trade Act of 1974, as amended by the Omnibus Trade and Competitiveness Act of 1988 and the Uruguay Round Agreements Act (enacted in 1994). This Report reflects the Administration’s resolve to encourage and maintain effective IPR protection and enforcement worldwide.

The following are copies of several years of the USTR Special 301 Report, as well as selected submissions by PhRMA and IIPA and commentary and submissions by others, followed by selected articles and reports about the Special 301 Report.


2009 Special 301

2008 Special 301

2007 Special 301

2006 Special 301

2005 Special 301

2004 Special 301

2003 Special 301

2002 Special 301

2001 Special 301

2000 Special 301

1999 Special 301

1998 Special 301

1997 Special 301

1996 Special 301

1995 Special 301

1994 Special 301

1993 Special 301

1992 Special 301

1991 Special 301

  • USTR's 1991 Special 301 Report.
  • January 25, 1991. Roger A Brooks from PhRMA writes to International Subcommittee of the Patent Committee, US Department of Commerce, stating that PhRMA "is in the process of formulating a Section 301 petition against Thailand for lack of intellectual property protection." He asks that the Subcommittee "evaluate the proposed changed in the current Thai Law" in view of the comments made by Pfizer, which he encloses.

1990 Special 301

1989 Special 301


Misc documents and studies